The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

Fri, 05th Aug 2022 14:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

----------

Condor Gold PLC - mine developer in Nicaragua - Gets the final results of metallurgical tests for a feasibility study conducted on the La India Open Pit. It was conducted by the Bureau Veritas Laboratories in Richmond, British Columbia. Says low-grade composites averaged 94% at the 75 micron target grind. Says study indicated a net metallurgical recovery of 91%, which will be used in the technical economic models for the forthcoming feasibility study.

----------

Novacyt SA - Surrey-based biotechnology group focused on clinical diagnostics - Launches its first fully freeze-dried direct-to-PCR assays. It enables the transportation of assays at ambient temperatures to remote regions or in areas without a centralised cold storage supply chain.

----------

Schroder British Opportunities Trust PLC - investment company - makes an additional investment into digital-first home healthcare firm Cera Care Ltd. The investment is part of a new funding round to accelerate Cera's growth. Anticipates that the funding round will lead to an uplift in the fair value of its existing holding in Cera of roughly GBP2.1 million, or an approximate uplift on its NAV of 2.8 pence per share, compared to the valuation as at March 31.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Confirms that it has received the first funding tranche of USD1.2 million under its new USD10 million financing facility with Mercer Street Global Opportunity Fund LLC. It is a fund managed by Mercer Street Capital Partners LLC.

----------

Hamak Gold Ltd - British Virgin Islands-based gold exploration firm focused on Liberia - Receives positive channel sampling results at its Nimba license. Intersects significant gold mineralization from its Block-1 grid. Says the results are suggestive of a bulk tonnage gold target.

----------

Star Phoenix Group Ltd - oil and gas company focused on Trinidad and Indonesia - Says its wholly owned subsidiary Range Resources Drilling Services Ltd has submitted three claims of GBP1.8 million against Range Resources Trinidad Ltd in the Supreme Court of Trinidad and Tobago. The claims are in respect of breach of loan, service and equipment rental contracts.

----------

4D Pharma PLC - Leeds, England-based pharmaceutical company - Says its administrators have published a proposal for members and creditors. Says it is uncertain whether rescuing the company in accordance with Paragraph 3,1,a is achievable, considering the uncertainty of the ongoing sale of business process. Aims to is to achieve a better result for the company's creditors as a whole. Notes that a wind-up could be possible.

----------

Critical Metals PLC - Africa-focused natural resources investor - Enters into an investment agreement with its wholly owned subsidiary Critical Metals Mauritius Ltd, Madini Occidental Ltd, and Madini Occidental's shareholders Russell Fryer and Madini Minerals.

----------

Online Blockchain PLC - Ongar, England-based cryptocurrency firm - Adds Optimism to its portfolio of bridges. It is a Layer 2 Ethereum scaling solution has a USD1.20 billion total value locked.

----------

GreenX Metals Ltd - developing Arctic Rift copper project in Greenland - Plans to deploy three advanced all-terrain vehicles for its exploration programme at the Arctic Rift Copper project in Greenland.

----------

First Class Metals PLC - Lancashire, England-based minerals exploration company - Starts ground exploration and reconnaissance work across six of the seven properties.

----------

United Oil & Gas PLC - oil and gas company operating in Egypt, Italy and UK - Finds 7 metres of net oil pay in the Primary Abu Roash C reservoir on its Abu Sennan licence, onshore Egypt. Plans for the testing programme to include both primary and secondary Abu Roash G targets. Optimistic about its prospects, with oil prices remaining high.

----------

Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - Starts next exploration phase at its Molopo Farms Complex Project in southwest Botswana. The project is targeting nickel, copper and platinum-group-element mineralisation. The next stage is planned diamond drilling. It is focused on the discovery of economic nickel sulphides and following up on the results from the drill programme completed in 2021.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
16 May 2019 09:59

4d Pharma To Present Data From Thetanix Clinical Study In San Diego

LONDON (Alliance News) - 4d Pharma PLC on Thursday said it will present the data from the completed phase Ib clinical study of Thetanix for the treatment of Crohn's disease on Saturday in San

Read more
29 Apr 2019 09:20

4d Pharma "Delighted" With Progress Being Made On Oncology Programme

LONDON (Alliance News) - 4d Pharma PLC on Monday reported a positive initial phase of one drug trial and the start of another.In a phase I/II trial of pembrolizumab, or Keytruda, the first

Read more
14 Mar 2019 09:53

DIRECTOR DEALINGS: 4D Pharma CEO And Chief Scientific Officer Buy

LONDON (Alliance News) - 4D Pharma PLC on Thursday said Chief Scientific Officer Alex Stevenson purchased 24,896 shares at a price of 91.5 pence each on Wednesday for a total of in 4D Pharma were

Read more
13 Mar 2019 15:36

DIRECTOR DEALINGS: 4d Pharma Non-Exec Chair And Director Buy Shares

LONDON (Alliance News) - 4d Pharma PLC on Wednesday said Non-Executive Chair David Norwood and Non-Executive Director Thomas Engelen both purchased shares in the AIM-listed pharmaceutical separate

Read more
29 Jan 2019 09:26

4D Pharma Reports Reveals MRx0518 Immune System Stimulatory Effect

LONDON (Alliance News) - 4D Pharma PLC said Tuesday tests have shown its MRx0518 cancer treatment has "strong immuno-stimulatory effects".Researchers at 4D demonstrated that - on

Read more
8 Jan 2019 10:57

4D Pharma Appoints Two Non-Executives From Xencor And Celgene

LONDON (Alliance News) - 4D Pharma PLC said Tuesday it has appointed two new independent non-executive directors, one a previous chief business officer at Xencor Inc and the other a former senior

Read more
7 Jan 2019 08:20

4d Pharma buoyed by Texas cancer treatment partnership

(Sharecast News) - 4d Pharma's shares enjoyed a boost on Monday after entering a collaboration with a specialist cancer unit at the University of Texas.

Read more
7 Jan 2019 07:57

4D Pharma Partners With Cancer Center For Cancer Treatment

LONDON (Alliance News) - 4D Pharma PLC on Monday said it has partnered with the University of Texas MD Anderson Cancer Center to evaluate its live biotherapeutic oncology pipeline.The will

Read more
12 Dec 2018 09:19

4d Pharma "Not Aware Of Matter" Responsible For Drop In Share Price

LONDON (Alliance News) - 4d Pharma PLC on Wednesday noted a recent fall in its share price, but said is not aware of any company-related reasons for the drop.The pharmaceutical company that

Read more
28 Sep 2018 10:41

4d Pharma Interim Loss Holds Steady Despite Rise In R&D Spending

LONDON (Alliance News) - 4d Pharma PLC on Friday said its loss widened only marginally in the first half of the year, despite significantly higher expenses, due to the absence of a non-recurring a

Read more
28 Sep 2018 08:29

4d Pharma losses little changed as trials begin

(Sharecast News) - First-half losses grew slightly at live biotherapeutics developer 4d Pharma as first-half research and development expenses jumped ahead of two of its major treatment candidates receiving clearance for clinical trials.

Read more
24 Sep 2018 14:19

Positive top-line results for 4D Pharma's Thetanix

(Sharecast News) - Biotherapeutics company 4D Pharma announced positive top-line results for its Phase 1b study of 'Thetanix' in paediatric patients with Crohn's disease on Monday.

Read more
24 Sep 2018 08:45

4d Pharma Reports Positive Results From Phase Ib Study Of Thetanix

LONDON (Alliance News) - 4d Pharma PLC on Monday said its phase Ib study of Thetanix in paediatric patients with Crohn's disease achieved its primary objective.Crohn's disease is a

Read more
12 Jun 2018 17:55

Janus Henderson Increases Stake In 4d Pharma To 5.2% (ALLISS)

LONDON (Alliance News) - 4d Pharma PLC said Janus Henderson Group PLC increased stake in the pharmaceutical company to 5.2% after a transaction on Tuesday.Janus Henderson raised its holding

Read more
21 May 2018 07:40

LONDON MARKET PRE-OPEN: FTSE 100 Set For All-Time Record At Open

LONDON (Alliance News) - The FTSE 100 is set to open at an all-time high on Monday, coming after trade tensions between the US and China eased over the weekend.In early UK company news on said the US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.